GlassScriptPhysician profile
Allen R Todd
NPI 1851739825
$972.01
in general payments reported to CMS, 2019-2025
12 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.58 · 2022: $91.75 · 2023: $176 · 2024: $251 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $247.39 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $185.69 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Lilly USA, LLC | $157.92 | 2019-2025 | Zepbound, Mounjaro |
| Abbvie INC. | $109.23 | 2022-2023 | Qulipta, Ubrelvy |
| Pfizer INC. | $75.98 | 2023-2024 | |
| Abbott Laboratories | $67.95 | 2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $35.61 | 2023-2024 | Airsupra, Breztri |
| Medtronic USA, INC. | $24.45 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.99 | 2024 | |
| Hologic Sales and Service, LLC | $18.20 | 2024 | Aptima |
| Astellas Pharma US INC | $15.78 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $13.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.